MKI67 and cancer: In addition, the expression levels of Ki67 exon 7-including splicing variant are significantly associated with patients’ overall survival in only three types of cancer, including colon cancer (p = 0.04), rectal cancer (p = 0.006), and lung cancer (p = 0.02) (Figure S1).